ARCHIVES

FDA Advisors Oppose Group’s Tamoxifen Trial, But Okay The Idea

This article is from The Cancer Letter archive.

Vol. 16 No. 27 | July 6, 1990

Download PDF Visit The Full Archive

Related Articles

In Brief: Longmire Reappointed to Panel; New Organ System Group For Brain-CNS Tumors Asked

April 26, 1985

As FDA Weighs its Options on Morcellation, Debate Erupts Over Harvard Device Study

November 21, 2014

Dendritic Cell Vaccine May Boost Median Survival

March 25, 2011

NALSO Members Urged To Police Selves, Adopt Ethics Code

August 4, 1978

NCI Clarifies Policy On Small, Short-Term Research Grants

July 5, 1996

Ludwig Cancer Research Donates $540 Million to Six Centers

January 10, 2014